United States — Selling, general, and administrative expenses
Edwards Lifesciences United States — Selling, general, and administrative expenses decreased by 7.3% to $154.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.7%, from $133.20M to $154.10M. Over 3 years (FY 2022 to FY 2025), United States — Selling, general, and administrative expenses shows an upward trend with a 19.1% CAGR.
Analysis
How to read this metric
An increase may signal aggressive investment in market expansion or product launches, whereas a decrease could indicate cost-cutting measures or improved operational leverage.
Detailed definition
This metric encompasses the operating expenses incurred to support sales, marketing, and administrative functions specif...
Peer comparison
Standard SG&A reporting across the medical device industry; peer companies often disclose these to show the cost of maintaining a specialized sales force.
ew_segment_united_states_selling_general_and_administrative_expensesHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $85.18M | $85.18M | $85.18M | $85.18M | $108.20M | $108.20M | $108.20M | $108.20M | $115.20M | $117.80M | $126.20M | $138.80M | $133.20M | $135.70M | $140.20M | $166.20M | $154.10M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +27.0% | +0.0% | +0.0% | +0.0% | +6.5% | +2.3% | +7.1% | +10.0% | -4.0% | +1.9% | +3.3% | +18.5% | -7.3% |
| YoY Change | — | — | — | — | +27.0% | +27.0% | +27.0% | +27.0% | +6.5% | +8.9% | +16.6% | +28.3% | +15.6% | +15.2% | +11.1% | +19.7% | +15.7% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's united states — selling, general, and administrative expenses?
- Edwards Lifesciences (EW) reported united states — selling, general, and administrative expenses of $154.10M in Q1 2026.
- How has Edwards Lifesciences's united states — selling, general, and administrative expenses changed year-over-year?
- Edwards Lifesciences's united states — selling, general, and administrative expenses increased by 15.7% year-over-year, from $133.20M to $154.10M.
- What is the long-term trend for Edwards Lifesciences's united states — selling, general, and administrative expenses?
- Over 3 years (2022 to 2025), Edwards Lifesciences's united states — selling, general, and administrative expenses has grown at a 19.1% compound annual growth rate (CAGR), from $340.70M to $575.30M.
- What does united states — selling, general, and administrative expenses mean?
- Operating costs related to selling, marketing, and administration within the United States.